perfosfamide has been researched along with Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| al-Achi, A; Henner, WD; Holden, SA; Rosbe, KW; Shea, TC; Teicher, BA; Wang, YY | 1 |
| Hoon, DB; Jung, T; McBride, WH; Morton, DL; Naungayan, J; Nizze, A | 1 |
2 other study(ies) available for perfosfamide and Melanoma
| Article | Year |
|---|---|
Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
Topics: Alkylating Agents; Antineoplastic Agents; Blotting, Northern; Carmustine; Cell Line; Cell Survival; Clone Cells; Cyclophosphamide; Drug Resistance; Glutathione Transferase; Humans; Melanoma; Melphalan; RNA, Neoplasm; Tumor Cells, Cultured | 1989 |
Cyclophosphamide-induced alterations in human monocyte functions.
Topics: Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Humans; Immunity, Cellular; Interleukin-1; Leukocytes, Mononuclear; Melanoma; Tumor Necrosis Factor-alpha; Vaccination | 1987 |